Cargando…

Association between rs1800629 polymorphism in tumor necrosis factor-α gene and dilated cardiomyopathy susceptibility: Evidence from case–control studies

OBJECTIVE: Several published studies have investigated the association between the −308G/A (rs1800629) polymorphism in the tumor necrosis factor-α (TNF-α) gene and the risk of dilated cardiomyopathy (DCM). However, the TNF-α gene polymorphism has a controversial role in the pathogenesis of DCM among...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yongdong, Cao, Yanhong, Xin, Linlin, Gao, Ningning, Liu, Bingshuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320213/
https://www.ncbi.nlm.nih.gov/pubmed/30557992
http://dx.doi.org/10.1097/MD.0000000000013386
_version_ 1783385197167771648
author Zhang, Yongdong
Cao, Yanhong
Xin, Linlin
Gao, Ningning
Liu, Bingshuang
author_facet Zhang, Yongdong
Cao, Yanhong
Xin, Linlin
Gao, Ningning
Liu, Bingshuang
author_sort Zhang, Yongdong
collection PubMed
description OBJECTIVE: Several published studies have investigated the association between the −308G/A (rs1800629) polymorphism in the tumor necrosis factor-α (TNF-α) gene and the risk of dilated cardiomyopathy (DCM). However, the TNF-α gene polymorphism has a controversial role in the pathogenesis of DCM among different populations. In the present study, a meta-analysis was performed to resolve this inconsistency. METHODS: Potentially eligible papers reporting an association between the TNF-α rs1800629 polymorphism and DCM susceptibility were searched in 4 databases including PubMed, EMBASE, Chinese Biomedical Database (CBM), and the Cochrane Library up to April 1, 2018. The odds ratio (OR) with its 95% confidence interval (CI) was used to estimate the strength of the associations. Subgroup analysis based on the ethnicity, studies with or without ischemic and valvular DCM was conducted. Publication bias detection was conducted using Begg test. RESULTS: Nine papers detailing case-control studies were included, reporting a total of 1339 DCM cases and 1677 healthy controls. The meta-analysis results indicated that TNF-α rs1800629 was associated with increased DCM susceptibility in the populations studied under the heterozygous model (AG vs GG: OR = 1.91, 95% CI = 1.05−3.50, P = .035) and dominant model (AG + AA vs GG: OR = 1.87, 95% CI = 1.01−3.45, P = .046). In the subgroup analysis for ethnicity, rs1800629 polymorphism was significantly associated with the susceptibility of DCM for Asians under the 5 models (A vs G: OR = 2.87, 95% CI = 1.56−5.30, P = .001; AA vs GG: OR = 3.95, 95% CI = 1.13−13.82, P = 0.031; AG vs GG: OR = 3.8, 95% CI = 1.57−9.19, P = .003; AA vs GG + AG: OR = 2.51, 95% CI = 1.41−4.49, P = .002; AG + AA vs GG: OR = 3.77, 95% CI = 1.54−9.20, P = .004). CONCLUSION: There may be a moderate association between TNF-α rs1800629 polymorphism and DCM susceptibility in the whole populations studied; however, TNF-α rs1800629 polymorphism was significantly associated with the susceptibility of DCM for Asians, which indicates that such associations may be different between ethnicities.
format Online
Article
Text
id pubmed-6320213
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-63202132019-01-14 Association between rs1800629 polymorphism in tumor necrosis factor-α gene and dilated cardiomyopathy susceptibility: Evidence from case–control studies Zhang, Yongdong Cao, Yanhong Xin, Linlin Gao, Ningning Liu, Bingshuang Medicine (Baltimore) Research Article OBJECTIVE: Several published studies have investigated the association between the −308G/A (rs1800629) polymorphism in the tumor necrosis factor-α (TNF-α) gene and the risk of dilated cardiomyopathy (DCM). However, the TNF-α gene polymorphism has a controversial role in the pathogenesis of DCM among different populations. In the present study, a meta-analysis was performed to resolve this inconsistency. METHODS: Potentially eligible papers reporting an association between the TNF-α rs1800629 polymorphism and DCM susceptibility were searched in 4 databases including PubMed, EMBASE, Chinese Biomedical Database (CBM), and the Cochrane Library up to April 1, 2018. The odds ratio (OR) with its 95% confidence interval (CI) was used to estimate the strength of the associations. Subgroup analysis based on the ethnicity, studies with or without ischemic and valvular DCM was conducted. Publication bias detection was conducted using Begg test. RESULTS: Nine papers detailing case-control studies were included, reporting a total of 1339 DCM cases and 1677 healthy controls. The meta-analysis results indicated that TNF-α rs1800629 was associated with increased DCM susceptibility in the populations studied under the heterozygous model (AG vs GG: OR = 1.91, 95% CI = 1.05−3.50, P = .035) and dominant model (AG + AA vs GG: OR = 1.87, 95% CI = 1.01−3.45, P = .046). In the subgroup analysis for ethnicity, rs1800629 polymorphism was significantly associated with the susceptibility of DCM for Asians under the 5 models (A vs G: OR = 2.87, 95% CI = 1.56−5.30, P = .001; AA vs GG: OR = 3.95, 95% CI = 1.13−13.82, P = 0.031; AG vs GG: OR = 3.8, 95% CI = 1.57−9.19, P = .003; AA vs GG + AG: OR = 2.51, 95% CI = 1.41−4.49, P = .002; AG + AA vs GG: OR = 3.77, 95% CI = 1.54−9.20, P = .004). CONCLUSION: There may be a moderate association between TNF-α rs1800629 polymorphism and DCM susceptibility in the whole populations studied; however, TNF-α rs1800629 polymorphism was significantly associated with the susceptibility of DCM for Asians, which indicates that such associations may be different between ethnicities. Wolters Kluwer Health 2018-12-14 /pmc/articles/PMC6320213/ /pubmed/30557992 http://dx.doi.org/10.1097/MD.0000000000013386 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle Research Article
Zhang, Yongdong
Cao, Yanhong
Xin, Linlin
Gao, Ningning
Liu, Bingshuang
Association between rs1800629 polymorphism in tumor necrosis factor-α gene and dilated cardiomyopathy susceptibility: Evidence from case–control studies
title Association between rs1800629 polymorphism in tumor necrosis factor-α gene and dilated cardiomyopathy susceptibility: Evidence from case–control studies
title_full Association between rs1800629 polymorphism in tumor necrosis factor-α gene and dilated cardiomyopathy susceptibility: Evidence from case–control studies
title_fullStr Association between rs1800629 polymorphism in tumor necrosis factor-α gene and dilated cardiomyopathy susceptibility: Evidence from case–control studies
title_full_unstemmed Association between rs1800629 polymorphism in tumor necrosis factor-α gene and dilated cardiomyopathy susceptibility: Evidence from case–control studies
title_short Association between rs1800629 polymorphism in tumor necrosis factor-α gene and dilated cardiomyopathy susceptibility: Evidence from case–control studies
title_sort association between rs1800629 polymorphism in tumor necrosis factor-α gene and dilated cardiomyopathy susceptibility: evidence from case–control studies
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320213/
https://www.ncbi.nlm.nih.gov/pubmed/30557992
http://dx.doi.org/10.1097/MD.0000000000013386
work_keys_str_mv AT zhangyongdong associationbetweenrs1800629polymorphismintumornecrosisfactorageneanddilatedcardiomyopathysusceptibilityevidencefromcasecontrolstudies
AT caoyanhong associationbetweenrs1800629polymorphismintumornecrosisfactorageneanddilatedcardiomyopathysusceptibilityevidencefromcasecontrolstudies
AT xinlinlin associationbetweenrs1800629polymorphismintumornecrosisfactorageneanddilatedcardiomyopathysusceptibilityevidencefromcasecontrolstudies
AT gaoningning associationbetweenrs1800629polymorphismintumornecrosisfactorageneanddilatedcardiomyopathysusceptibilityevidencefromcasecontrolstudies
AT liubingshuang associationbetweenrs1800629polymorphismintumornecrosisfactorageneanddilatedcardiomyopathysusceptibilityevidencefromcasecontrolstudies